364 related articles for article (PubMed ID: 12886507)
1. [Indication and effect of immunosuppression in patients with scleritis].
Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
[TBL] [Abstract][Full Text] [Related]
2. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.
Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G
Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic non-infectious uveitis and scleritis.
Rossi DC; Ribi C; Guex-Crosier Y
Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
[TBL] [Abstract][Full Text] [Related]
5. Episcleritis and scleritis: clinical features and treatment results.
Jabs DA; Mudun A; Dunn JP; Marsh MJ
Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
[TBL] [Abstract][Full Text] [Related]
6. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
11. Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis.
Hwang YS; Chen HC; Chen KJ; Lai CC; Yeung L; Yang KJ; Lin KK; Hsiao CH
Cornea; 2011 Mar; 30(3):260-4. PubMed ID: 21099416
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE
Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and visual outcomes of Japanese patients with scleritis.
Keino H; Watanabe T; Taki W; Nakashima C; Okada AA
Br J Ophthalmol; 2010 Nov; 94(11):1459-63. PubMed ID: 20576778
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
[TBL] [Abstract][Full Text] [Related]
15. [Scleritis: clinical characteristics, systemic associations, treatment and outcome in 100 patients].
Machado Dde O; Curi AL; Fernandes RS; Bessa TF; Campos WR; Oréfice F
Arq Bras Oftalmol; 2009; 72(2):231-5. PubMed ID: 19466335
[TBL] [Abstract][Full Text] [Related]
16. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
17. [Systemic management of autoimmune anterior uveitis].
Bachta A; Tłustochowicz M
Klin Oczna; 2005; 107(10-12):710-4. PubMed ID: 16619827
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.
Becker MD; Wertheim MS; Smith JR; Rosenbaum JT
Ocul Immunol Inflamm; 2005; 13(4):289-93. PubMed ID: 16159719
[TBL] [Abstract][Full Text] [Related]
19. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
Denk PO; Thiel HJ; Zierhut M
Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment].
Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J
Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
